This in silico analysis, together with our experimental data showing that CYP1B1 expression increase following cisplatin stimulation, support the hypothesis that the increase in CYP1B1 is due to cisplatin treatment and not the tumor itself. The gene discussed is CYP1B1; the disease is neoplasm.